| Update on melatonin receptors: IUPHAR Review 20 R Jockers, P Delagrange, ML Dubocovich, RP Markus, N Renault, ... British journal of pharmacology 173 (18), 2702-2725, 2016 | 405 | 2016 |
| MT1 and MT2 Melatonin Receptors: Ligands, Models, Oligomers, and Therapeutic Potential DP Zlotos, R Jockers, E Cecon, S Rivara, PA Witt-Enderby Journal of medicinal chemistry 57 (8), 3161-3185, 2014 | 202 | 2014 |
| Recent advances in melatonin receptor ligands DP Zlotos Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2005 | 140 | 2005 |
| Discovery of nanomolar dengue and West Nile virus protease inhibitors containing a 4-benzyloxyphenylglycine residue MAM Behnam, D Graf, R Bartenschlager, DP Zlotos, CD Klein Journal of medicinal chemistry 58 (23), 9354-9370, 2015 | 114 | 2015 |
| Allosteric site on muscarinic acetylcholine receptors: a single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and … S Buller, DP Zlotos, K Mohr, J Ellis Molecular pharmacology 61 (1), 160-168, 2002 | 84 | 2002 |
| Pharmacological characterisation of strychnine and brucine analogues at glycine and α7 nicotinic acetylcholine receptors AA Jensen, P Gharagozloo, NJM Birdsall, DP Zlotos European journal of pharmacology 539 (1-2), 27-33, 2006 | 60 | 2006 |
| Recent progress in the development of agonists and antagonists for melatonin receptors D P Zlotos Current medicinal chemistry 19 (21), 3532-3549, 2012 | 54 | 2012 |
| Melatonin receptor ligands: a pharmaco‐chemical perspective JA Boutin, PA Witt‐Enderby, C Sotriffer, DP Zlotos Journal of pineal research 69 (3), e12672, 2020 | 47 | 2020 |
| Drug conjugates—an emerging approach to treat breast cancer M Hasan, RK Leak, RE Stratford, DP Zlotos, PA Witt‐Enderby Pharmacology research & perspectives 6 (4), e00417, 2018 | 44 | 2018 |
| Bisquaternary Ligands of the Common Allosteric Site of M2 Acetylcholine Receptors: Search for the Minimum Essential Distances between the Pharmacophoric … T Nassif-Makki, C Tränkle, D Zlotos, G Bejeuhr, A Cambareri, ... Journal of medicinal chemistry 42 (5), 849-858, 1999 | 40 | 1999 |
| Pharmacological, mechanistic, and pharmacokinetic assessment of novel melatonin-tamoxifen drug conjugates as breast cancer drugs M Hasan, MA Marzouk, S Adhikari, TD Wright, BP Miller, MD Matossian, ... Molecular Pharmacology 96 (2), 272-296, 2019 | 39 | 2019 |
| 2-[(2,3-Dihydro-1H-indol-1-yl)methyl]melatonin Analogues: A Novel Class of MT2-Selective Melatonin Receptor Antagonists DP Zlotos, MI Attia, J Julius, S Sethi, PA Witt-Enderby Journal of medicinal chemistry 52 (3), 826-833, 2009 | 35 | 2009 |
| N‐Acetyl‐5‐arylalkoxytryptamine Analogs: Probing the Melatonin Receptors for MT1‐Selectivity C Markl, WP Clafshenkel, MI Attia, S Sethi, PA Witt‐Enderby, DP Zlotos Archiv der Pharmazie 344 (10), 666-674, 2011 | 31 | 2011 |
| Bisquaternary caracurine V derivatives as allosteric modulators of ligand binding to M2 acetylcholine receptors DP Zlotos, S Buller, C Tränkle, K Mohr Bioorganic & medicinal chemistry letters 10 (22), 2529-2532, 2000 | 31 | 2000 |
| Synthesis, NMR conformational analysis and pharmacological evaluation of 7, 7a, 13, 14-tetrahydro-6 H-cyclobuta [b] pyrimido [1, 2-a: 3, 4-a′] diindole analogues as melatonin … MI Attia, D Güclü, B Hertlein, J Julius, PA Witt-Enderby, DP Zlotos Organic & Biomolecular Chemistry 5 (13), 2129-2137, 2007 | 28 | 2007 |
| Muscarinic receptor agonists and antagonists DP Zlotos, W Bender, U Holzgrabe Expert Opinion on Therapeutic Patents 9 (8), 1029-1053, 1999 | 28 | 1999 |
| Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel … C Markl, MI Attia, J Julius, S Sethi, PA Witt-Enderby, DP Zlotos Bioorganic & medicinal chemistry 17 (13), 4583-4594, 2009 | 24 | 2009 |
| Probing the Pharmacophore for Allosteric Ligands of Muscarinic M2 Receptors: SAR and QSAR Studies in a Series of Bisquaternary Salts of Caracurine V and … DP Zlotos, S Buller, N Stiefl, K Baumann, K Mohr Journal of medicinal chemistry 47 (14), 3561-3571, 2004 | 24 | 2004 |
| Bisquaternary dimers of strychnine and brucine. A new class of potent enhancers of antagonist binding to muscarinic M2 receptors DP Zlotos, S Buller, U Holzgrabe, K Mohr Bioorganic & medicinal chemistry 11 (12), 2627-2634, 2003 | 23 | 2003 |
| PPAR gamma activators: off-target against glioma cell migration and brain invasion S Seufert, R Coras, C Tränkle, DP Zlotos, I Blümcke, L Tatenhorst, ... PPAR research 2008, 2008 | 22 | 2008 |
Ralf JockersVerified email at inserm.fr
